Cubist Pharmaceuticals has appointed a new chief financial officer. The new top finance executive at the company is Michael Tomsicek, who replaces the outgoing David McGirr.
Tomsicek has been senior vice president and deputy CFO since July of last year. He joined the company in 2010 as vice president of corporate finance. Before that, he worked for eight years at General Electric Healthcare, serving as finance manager of global operations, CFO of the diagnostic ultrasound segment, and CFO of the global ultrasound product group.
Tomsicek's predecessor, McGirr, will become senior advisor to the chief executive officer and retire next year.
The article Cubist Names New CFO originally appeared on Fool.com.
Fool contributor Eric Volkman has no position in Cubist Pharmaceuticals. The Motley Fool recommends Cubist Pharmaceuticals. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.